Dosing begins in first-in-human study of CAN-106 for complement dysregulation diseases March 10, 2021 No Comments
FDA accepts IND application for EP-7041 for thrombosis prevention in patients with COVID-19 March 4, 2021 No Comments
Initiation of phase IIa study evaluating BGE-117 in elderly with unexplained anemia Feb. 26, 2021 No Comments
Enrollment completed in phase II study of SSS-06 long-acting erythropoietin-stimulating protein Feb. 25, 2021 No Comments
New phase I study evaluates AbFero's SP-420 to treat transfusional iron overload Feb. 24, 2021 No Comments
bluebird bio temporary suspends studies of LentiGlobin gene therapy for SCD Feb. 17, 2021 No Comments
RSS